Internal Medicine, Hematology & Oncology · Moline, IL
NPI
1770553349
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
600 John Deere Road, Suite 200
Moline, IL, 61265
Phone (309) 779-4200
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
2,960 services
Medicare patients, 2024
451
Average age 75
Drug cost, 2024
$6.5M
3,387 prescriptions
Company payments, 2025
$4,001
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Porubcin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,288 times for 406 patients. In total Michael Porubcin billed 2,960 services in 5 codes, and Medicare paid $154K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 1,288 | 406 | $12.32 | $16K |
| 99214 Office E&M - Established | Facility | 930 | 329 | $67.73 | $63K |
| 99215 Office E&M - Established | Facility | 675 | 284 | $100.27 | $68K |
| 99205 Office E&M - New | Facility | 65 | 65 | $114.87 | $7,467 |
By year: 2022 $136K for 1,928 services; 2023 $124K for 1,701 services; 2024 $154K for 2,960 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Porubcin prescribed most often to Medicare patients was Eliquis (Apixaban), with 376 prescriptions and refills. In total Michael Porubcin wrote 3,387 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 376 | 451 | 64 | $254K |
| Anastrozole Generic | 279 | 607 | 66 | $4,162 |
| Prednisone Generic | 184 | 212 | 46 | $983 |
| Letrozole Generic | 159 | 335 | 39 | $3,083 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 157 | 160 | 51 | $2,887 |
| Hydroxyurea Generic | 154 | 254 | 27 | $3,397 |
| Levothyroxine Sodium Generic | 138 | 231 | 30 | $505 |
| Calquence Acalabrutinib Maleate | 103 | 103 | Under 11 | $1.4M |
| Warfarin Sodium Generic | 97 | 148 | Under 11 | $879 |
| Gabapentin Generic | 84 | 88 | 21 | $946 |
| Xarelto Rivaroxaban | 79 | 104 | 13 | $58K |
| Kisqali Ribociclib Succinate | 66 | 66 | Under 11 | $767K |
| Potassium Chloride Generic | 63 | 87 | 12 | $599 |
| Ondansetron Hcl Generic | 63 | 63 | 35 | $977 |
| Dexamethasone Generic | 56 | 83 | 26 | $791 |
Brand drugs: - claims; generic drugs: 2,390 claims; opioid claims: 333.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Porubcin $4,001 ($4,001 in general payments such as food, travel and fees) from 38 companies. The largest payer was Novartis Pharmaceuticals Corporation with $452.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 22 | $452 |
| Janssen Biotech, Inc. JNJ | 20 | $375 |
| Daiichi Sankyo Inc. 4568.T | 15 | $302 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $262 |
| Abbvie Inc. ABBV | 13 | $222 |
| Merck Sharp & Dohme LLC MRK | 10 | $200 |
| Eisai Inc. 4523.T | 5 | $170 |
| Astellas Pharma US Inc 4503.T | 5 | $169 |
| Pfizer Inc. PFE | 10 | $169 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.